Technical Analysis for CERT - Certara, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | -1.52% | |
| Wide Bands | Range Expansion | -1.52% | |
| Oversold Stochastic | Weakness | -1.52% | |
| Inside Day | Range Contraction | -0.07% | |
| Wide Bands | Range Expansion | -0.07% | |
| Oversold Stochastic | Weakness | -0.07% | |
| Wide Bands | Range Expansion | -2.15% | |
| Oversold Stochastic | Weakness | -2.15% |
| Alert | Time |
|---|---|
| Down 3% | about 7 hours ago |
| 60 Minute Opening Range Breakdown | about 8 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
| 10 DMA Support | about 10 hours ago |
| Down 2 % | about 11 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 08/07/2024
Certara, Inc. Description
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Health Sciences Pharmacy Medication Drug Discovery Pharmacology Drug Development Pharmaceutical Sciences Systems Biology Medical Communications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.8702 |
| 52 Week Low | 11.81 |
| Average Volume | 609,506 |
| 200-Day Moving Average | 15.97 |
| 50-Day Moving Average | 16.02 |
| 20-Day Moving Average | 14.94 |
| 10-Day Moving Average | 13.69 |
| Average True Range | 0.66 |
| RSI (14) | 35.48 |
| ADX | 36.17 |
| +DI | 9.50 |
| -DI | 27.52 |
| Chandelier Exit (Long, 3 ATRs) | 15.79 |
| Chandelier Exit (Short, 3 ATRs) | 15.01 |
| Upper Bollinger Bands | 17.86 |
| Lower Bollinger Band | 12.03 |
| Percent B (%b) | 0.28 |
| BandWidth | 39.02 |
| MACD Line | -0.82 |
| MACD Signal Line | -0.76 |
| MACD Histogram | -0.0546 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.47 | ||||
| Resistance 3 (R3) | 14.49 | 14.23 | 14.33 | ||
| Resistance 2 (R2) | 14.23 | 14.02 | 14.22 | 14.28 | |
| Resistance 1 (R1) | 13.94 | 13.89 | 13.81 | 13.92 | 14.24 |
| Pivot Point | 13.68 | 13.68 | 13.62 | 13.67 | 13.68 |
| Support 1 (S1) | 13.39 | 13.47 | 13.26 | 13.37 | 13.04 |
| Support 2 (S2) | 13.13 | 13.34 | 13.12 | 13.00 | |
| Support 3 (S3) | 12.84 | 13.13 | 12.95 | ||
| Support 4 (S4) | 12.82 |
